Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Kewei Medical Instrument

    • Home
    • Kewei Medical Instrument
Company Deals Medical Device

MicroPort CardioFlow Secures Exclusive Distribution Rights for Evermend Occluders in China

Fineline Cube Jul 22, 2024

MicroPort Scientific Corp (HKG: 0853), a leading medical device company based in China, has announced...

Recent updates

  • Medtronic Plans to Spin Off Diabetes Business into Publicly Traded Entity
  • Bayer Launches Phase I Study of BAY 3670549 for Atrial Fibrillation
  • InnoCare Pharma’s Minjuvi Gains NMPA Approval for DLBCL Treatment
  • Uni-Bio Science’s Generic Diquas Accepted for NMPA Review
  • MicusRx’s Contezolid Sodium NDA Accepted for Review by NMPA
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Medical Device

Medtronic Plans to Spin Off Diabetes Business into Publicly Traded Entity

Company Drug

Bayer Launches Phase I Study of BAY 3670549 for Atrial Fibrillation

Company Drug

InnoCare Pharma’s Minjuvi Gains NMPA Approval for DLBCL Treatment

Company Drug

Uni-Bio Science’s Generic Diquas Accepted for NMPA Review

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.